Market Brief

The articles are produced in Chinese only.

Author

袁鉅文先生 (Aman Yuen)
經理

金融經濟系畢業, 從事股票衍生工具投資工作已有十年, 善於技術分析及期權買賣策略.歡迎各位來電交流心得
Phone:
36670666

中國人壽有限公司(2628)業務穩定

Wednesday, December 19, 2018 Views1920

中國人壽壽險業務總保費為人民幣3,043.41 億元,同比增長1.2%,佔總保費收入的比重為84.43%,同比下降2.53個百分點;其中,首年期交保費為人民幣769.18億元,同比增長5.4%,首年期交保費佔首年業務的比重為88.40%,同比上升34.07 個百分點;躉交保費為人民幣100.89 億元,同比下降83.6%,佔首年業務的比重為11.60%,同比下降34.07 個百分點;續期保費達人民幣2,173.34 億元,同比增長30.5%,佔壽險業務總保費的比重為71.41%,同比提升16.05 個百分點。

健康險業務總保費為人民幣480.90 億元,同比增長28.8%,佔總保費收入的比重為13.34%,同比提升2.55 個百分點。

意外險業務總保費為人民幣80.51 億元,同比增長3.4%,佔總保費收入的比重為2.23%,同比下降0.02 個百分點。

 

公司股東的淨利潤為人民幣164.23 億元,同比增長34.2%。截至2018 年6 月30日,公司內含價值達人民幣7,692.25億元,較2017年底增長4.8%。上半年新業務價值為人民幣281.66億元,同比下降23.7%。公司長險有效保單數量達2.75億份,較2017年底增長2.6%;保單持續率(14個月及26 個月)分別達92.30%和86.80%,同比分別提升0.7、1.0 個百分點。

建議:

沽出2019年1月股票期權認沽期權
正股在12月19日最低價: $16.42
期權合約:CLI15.5M9
行使價:15.5
類別: 認沽期權
期權金:0.25( 目標沽出價 )
金額: 10張是正股10000股
風險: 需要以$15.5買入正股 (如果被行使)
直至1月結算日: 27天
資料更新日期為2018年12月19日

 

本人袁鉅文為證監會持牌人士。截至本評論文章發表日止,本人及/或其有聯繫者並無持有全部提及之證券的所有相關財務權益。

 

 

This report is produced and is being distributed in Hong Kong by Phillip Securities Group with the Securities and Futures Commission (“SFC”) licence under Phillip Securities (HK) LTD and/ or Phillip Commodities (HK) LTD (“Phillip”). Information contained herein is based on sources that Phillip believed to be accurate. Phillip does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The information is for informative purposes only and is not intended to or create/induce the creation of any binding legal relations. The information provided do not constitute investment advice, solicitation, purchase or sell any investment product(s). Investments are subject to investment risks including possible loss of the principal amount invested. You should refer to your Financial Advisor for investment advice based on your investment experience, financial situation, any of your particular needs and risk preference. For details of different product's risks, please visit the Risk Disclosures Statement on http://www.phillip.com.hk. Phillip (or employees) may have positions/ interests in relevant investment products. Phillip (or one of its affiliates) may from time to time provide services for, or solicit services or other business from, any company mentioned in this report. The above information is owned by Phillip and protected by copyright and intellectual property Laws. It may not be reproduced, distributed or published for any purpose without prior written consent from Phillip.
Top of Page
Contact Us
Please contact your account executive or call us now.
Research Department
Tel : (852) 2277 6846
Fax : (852) 2277 6565
Email : businessenquiry@phillip.com.hk

Enquiry & Support
Branches
The Complaint Procedures
E-Check
Login
Louis Talk
Investor Notes
Free Subscribe
Contact Us